Despite major breakthroughs in identifying and combating respiratory diseases, two of the most prevalent – respiratory syncytial virus (RSV) and pneumococcal disease – continue to pose a significant health burden globally, particularly in infants, young children, and older adults.  Against this backdrop, a recent panel at the European Society for Paediatric Infectious Diseases (ESPID) meeting, […] Continue reading ->